Skip to main content

Table 1 Renal functional parameters in the study groups (mean ± SD)

From: Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats

 

NDCM (n = 8)

D (n = 8)

DR (n = 8)

DCM (n = 8)

DRCM (n = 8)

Serum creatinine (mg/dl)

0.56 ± 0.05#

0.36 ± 0.03

0.38 ± 0.03

0.89 ± 0.06*

0.42 ± 0.04+

Serum BUN (mg/dl)

14.98 ± 1.62

15.23 ± 1.32

16.26 ± 1.48

16.38 ± 1.93

16.45 ± 1.53

Creatinine clearance (ml/min)

1.53 ± 0.18#

2.68 ± 0.25

2.59 ± 0.24

1.08 ± 0.09*

1.98 ± 0.22+

FENa (%)

0.32 ± 0.15

0.29 ± 0.10

0.28 ± 0.09

0.31 ± 0.14

0.33 ± 0.13

Urine microprotein (mg/dl)

70.2 ± 22.1#

45.2 ± 11.3

38.6 ± 14.3

108.5 ± 23.4*

69.3 ± 18.2#

  1. NDCM: non-diabetic rats + contrast media, D: diabetic group, DCM: diabetic rats treat + contrast media, DR: diabetic rats + rosuvastatin, DRCM: diabetic rats + rosuvastatin + contrast media.
  2. *P < 0.01 vs NDCM, D, D R and DRCM; + P < 0.05 vs NDCM, D and DR, # P < 0.05 vs D, DR.